Adial Pharmaceuticals (ADIL) Q2 2024 Earnings
ADIL·Reported August 13, 2024·Before market open
Diluted EPS came in at $-0.59, missed the $-0.39 consensus by $0.20.
Diluted EPS
$-0.59missed by $0.20
Consensus: $-0.39
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Adial Pharmaceuticals's Q2 2024 earnings report.
Adial Pharmaceuticals (ADIL) reported Q2 2024 earnings on August 13, 2024 before market open.
Adial Pharmaceuticals reported diluted EPS of $-0.59 for Q2 2024.
EPS missed the consensus estimate of $-0.39 by $0.20.
You can read the 10-Q periodic report (0001213900-24-068262) directly on SEC EDGAR. The filing index links above go to sec.gov.